WFG Advisors, LP - RAPTOR PHARMACEUTICAL CORP ownership

RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 109 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q3 2015. The put-call ratio across all filers is 1.06 and the average weighting 0.1%.

Quarter-by-quarter ownership
WFG Advisors, LP ownership history of RAPTOR PHARMACEUTICAL CORP
ValueSharesWeighting
Q3 2015$1,000
-90.9%
145
-79.1%
0.00%
-100.0%
Q2 2015$11,000
+83.3%
695
+33.7%
0.00%
+50.0%
Q1 2015$6,000
+20.0%
5200.0%0.00%
+100.0%
Q4 2014$5,0000.0%520
+10.6%
0.00%0.0%
Q3 2014$5,0000.0%4700.0%0.00%0.0%
Q2 2014$5,000
+400.0%
470
+394.7%
0.00%
Q1 2014$1,0000.0%95
-5.0%
0.00%
Q4 2013$1,0001000.00%
Other shareholders
RAPTOR PHARMACEUTICAL CORP shareholders Q3 2015
NameSharesValueWeighting ↓
SV Health Investors, LLC 888,132$7,966,0006.12%
LONGFELLOW INVESTMENT MANAGEMENT CO LLC 1,054,678$9,460,0003.30%
Kassirer Asset Management Corp 363,700$3,262,0002.36%
WATER ISLAND CAPITAL LLC 3,359,140$30,131,0001.91%
Banco BTG Pactual S.A. 338,889$3,040,0001.43%
GARDNER LEWIS ASSET MANAGEMENT L P 1,941,012$17,411,0001.41%
FIRST NEW YORK SECURITIES LLC /NY 237,500$2,130,375,0001.41%
ALPINE ASSOCIATES MANAGEMENT INC. 3,804,600$34,089,0001.25%
Atika Capital Management LLC 300,000$2,691,0001.10%
Atika Capital Management LLC 298,200$2,672,0001.09%
View complete list of RAPTOR PHARMACEUTICAL CORP shareholders